XM
CALA

XTX Markets’s Calithera Biosciences, Inc CALA Stock Holding History

XTX Markets’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$50K Buy
+507
New +$44.4K 0.1% 182

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

XTX Markets's CALA Position: Q4 2020 in Review

XTX Markets opened a new position in Calithera Biosciences, Inc (CALA) in Q4 2020: 507 shares worth $50K. The stake represents 0.1% of the portfolio and ranks #182 among its holdings.

105 funds tracked by Wall St. Rank hold CALA as of Q4 2020.

  • XTX Markets held 507 shares of Calithera Biosciences, Inc worth $50K as of Q4 2020.
  • Calithera Biosciences, Inc was a new XTX Markets position in Q4 2020.
  • Calithera Biosciences, Inc made up 0.1% of XTX Markets's portfolio in Q4 2020, its #182 holding.
  • 105 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2020.

Based on XTX Markets's 13F filing for Q4 2020, filed 25 Jan 2021.